Evidence map›Paper›PMID 40463521›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.

Selina Pi, Carolyn M Rutter, Carlos Pineda-Antunez, Jonathan H Chen, Jeremy D Goldhaber-Fiebert, Fernando Alarid-Escudero

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Selina PiDepartment of Biomedical Data Science, School of Medicine, Stanford University, Palo Alto, CA.ORCID 0000-0002-9940-1925
Carolyn M RutterHutch Institute for Cancer Outcomes Research, Biostatistics Program, Public Health Sciences Division, Fred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-4396-8594
Carlos Pineda-AntunezThe Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA.ORCID 0000-0002-8352-7080
Jonathan H ChenStanford Center for Biomedical Informatics Research, Stanford University, Palo Alto, CA.ORCID 0000-0002-4387-8740
Jeremy D Goldhaber-FiebertDepartment of Health Policy, School of Medicine, Stanford University, Stanford, CA.ORCID 0000-0002-4007-5192
Fernando Alarid-EscuderoDepartment of Health Policy, School of Medicine, Stanford University, Stanford, CA.ORCID 0000-0001-5076-1172

Funding

POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
Comparative Modeling of Effective Policies for Colorectal Cancer ControlU01CA253913 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI RUTTER, CAROLYN M, ZAUBER, ANN GRAHAM · 2020 to 2025
$6.5M
Population Modeling of Bladder Cancer Detection and ControlU01CA265750 · NCI · BROWN UNIVERSITY · PI JALAL, HAWRE, TRIKALINOS, THOMAS · 2021 to 2025
$3.4M
NCI NIH HHS U01 CA253913NCI NIH HHS U01 CA265750NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Simulation models inform health policy decisions by integrating data from multiple sources and forecasting outcomes when there is a lack of comprehensive evidence from empirical studies. Such models have long supported health policy for cancer, the first or second leading cause of death in over 100 countries. Discrete-event simulation (DES) and Bayesian calibration have gained traction in the field of Decision Science because they enable efficient and flexible modeling of complex health conditions and produce estimates of model parameters that reflect real-world disease epidemiology and data uncertainty given model constraints. This uncertainty is then propagated to model-generated outputs, enabling decision makers to determine the optimal strategy to recommend, assess confidence in the recommendation, and estimate the value of collecting additional information. However, there is limited end-to-end guidance on structuring a DES model for cancer progression, estimating its parameters using Bayesian calibration, and applying the calibration outputs to policy evaluation and other downstream tasks. To fill this gap, we introduce the

Indexed as

Bayesian calibrationcancerdecision-analytic modelingdiscrete-event simulationmicrosimulationscreening

Identifiers

PMID40463521
PMCPMC12132142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.